Completed OBSERVATIONAL NCT04935463

Mucormycosis in COVID-19 (MUNCO)

Sponsor: AIIMS Patna

Conditions Aspergillosis Candida Infection Covid19 Mucormycosis

Updated 6 times since 2021 Last updated: Apr 14, 2023 Started: May 24, 2021 Primary completion: Mar 1, 2022 Completion: Mar 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Aspergillosis and Candida Infection, this trial is completed. The trial is conducted by AIIMS Patna and has accumulated 6 data snapshots since 2021. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
May 2023 — Jul 2024 [monthly]

Completed
Jun 2022 — May 2023 [monthly]

Completed

Status: Enrolling By Invitation → Completed

▶ Show 1 earlier version

Sep 2021 — Jun 2022 [monthly]

Enrolling By Invitation

First recorded

May 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AIIMS Patna
HCG Oncology Bangalore
Medanta Institute Delhi
Montefiore Medical Center
NSCB Jabalpur

Data source: Montefiore Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• The Bronx, United States